6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
36m ago	Eyebright Medical Releases Its 2025 Annual Report and Sustainability Report
36m ago	The Trade Desk Powers Open Internet Growth with DramaBox Short Drama Partnership
1h ago	Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
2h ago	Sun Pharma signs Definitive Agreement to Acquire Organon
5h ago	Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss

About

Hoth Therapeutics Inc (NASDAQ:HOTH) — investor relations, events, news, and company updates on 6ix.

Latest News

Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide

Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering

Hoth Therapeutics Announces $2.0 Million Registered Direct Offering

Hoth Therapeutics Announces Issuance of Chinese Patent for Cancer Cell-Targeting Technology

Hoth Therapeutics Deploys OpenClaw™ AI Platform to Accelerate Drug Discovery

Financials

Revenue

$0

Market Cap

$9.41 M

EPS

-0.90

Community Chat

Ask AI

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren